NEO: Material agreement · New financial obligation · Unregistered securities sale · Other company developments

Item 1.01 Entry Into or Amendment of a Material Definitive Agreement. Indenture and Notes On June 22, 2026, NeoGenomics, Inc. (the “Company”) completed its previously announced offering of $275.0 million in aggregate principal amount of 0.75% Convertible Senior Notes due 2032 (the “Initial Notes”). On June 17, 2026, the initial purchasers in such offering exercised their option to purchase an additional $41.25 million in aggregate principal amount of the Company’s 0.75% Convertible Senior Notes due 2032 (the “Additional Notes” and, together with the Initial Notes, the “Notes”), bringing the total aggregate principal amount of the Notes to $316.25 million. The Notes are the Company’s senior unsecured obligations. The Notes were issued pursuant to an Indenture, dated June 22, 2026 (the “Indenture”), by and between the Company and U.S. Bank Trust Company, National Association, as trustee. The Indenture includes customary covenants and sets forth certain events of default after which the Notes may be declared immediately due and payable, as well as certain types of bankruptcy or insolvency events of default involving the Company after which the Notes become automatically due and payable. The Notes will bear interest at a rate of 0.75% per annum, payable semiannually in arrears on January 1 and July 1 of each year, beginning on January 1, 2027. The Notes will mature on July 1, 2032, unless earlier converted, redeemed or repurchased. Before April 1, 2032, noteholders will have the right to convert their Notes in certain circumstances and during specified periods. From and after April 1, 2032, the Notes will be convertible at the option of the noteholders at any time prior to the close of business on the second scheduled trading day immediately preceding the maturity date. The